David Weissberg

The FDA seeks a cure for stem cell quackery

By GREGORY ZELLER // With federal regulators looming and a charged FDA hearing set for later this year, the nation’s stem cell community is tense, particularly clinicians incorporating stem cell therapies in private practice. Scientifically, stem cells are on the rise. Therapies cultivating stem cells from a patient’s own body are increasingly common treatments for autism, various cancers, joint injuries and a host of other ailments; nutritionists push supplements infused with stem cells, goji berry and…